Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
2.010
-0.080 (-3.83%)
At close: Jul 31, 2026, 4:00 PM EDT
1.950
-0.060 (-2.99%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Cadrenal Therapeutics Stock Forecast
CVKD's stock price has decreased by -80.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Cadrenal Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $16.67. The average 1-year stock price forecast is 729.35% higher than the current stock price, while the lowest is $12 (+497.01%) and the highest is $25 (+1,143.78%).
Price Target: $16.67 (+729.35%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cadrenal Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +546.77% | Jul 22, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $45 | Buy | Reiterates | $45 | +2,138.81% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.19
from -6.64
EPS Next Year
-3.09
from -3.19
EPS and Forward PE are based on non-GAAP adjusted numbers.